Literature DB >> 9205235

Dilated duct pattern at mammography.

P T Huynh1, J A Parellada, E S de Paredes, J Harvey, D Smith, L Holley, M Maxin.   

Abstract

PURPOSE: To determine the importance of a dilated duct pattern at mammography.
MATERIALS AND METHODS: Mammograms obtained in 46 women with histopathologically proved, asymmetrically dilated ducts were retrospectively studied. The laterality and location of the asymmetrically dilated duct, the presence of branching, and associated findings such as microcalcifications, nipple discharge, and interval change were evaluated.
RESULTS: Eleven patients (24%) had malignant results (ductal carcinoma in situ or invasive ductal carcinoma). Among these, six (54%) had suspicious microcalcifications. Nonsubareolar location and interval change are significant (P = .04) variables associated with malignancy.
CONCLUSION: Mammographic asymmetrically dilated ducts in a nonsubareolar area that are associated with interval change, suspicious microcalcifications, or both warrant biopsy.

Entities:  

Mesh:

Year:  1997        PMID: 9205235     DOI: 10.1148/radiology.204.1.9205235

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  Ultrasonographic alterations associated with the dilatation of mammary ducts: feature analysis and BI-RADS assessment.

Authors:  Hsian-He Hsu; Jyh-Cherng Yu; Giu-Cheng Hsu; Wei-Chou Chang; Cheng-Ping Yu; Ho-Jui Tung; Ching Tzao; Guo-Shu Huang
Journal:  Eur Radiol       Date:  2009-08-26       Impact factor: 5.315

2.  The nipple-areolar complex: anatomy, methods and pathologic findings, between senologist and dermatologist.

Authors:  Basile Luigi; Varelli Carlo; Caiazzo Corrado; Catalano Orlando
Journal:  J Ultrasound       Date:  2022-09-09

3.  Outcomes of solitary dilated breast ducts in symptomatic and asymptomatic patients.

Authors:  Sadia Choudhery; Curtis Simmons; Genevieve A Woodard; Asha A Bhatt; Tara L Anderson; Christine U Lee
Journal:  Br J Radiol       Date:  2020-02-28       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.